Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for reduction of serum C-reactive protein in hemodialysis patients
IRCT138901293744N1Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pentoxifylline in end-stage kidney disease (ESKD), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Serum C-reactive protein level. Started Jul 2009; status: completed.
02
Drugs
pentoxifylline
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT138901293744N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138901293744N1.